Category: Today’s Highlights
Trick or Trade?
Read More
April 26, 2019
0
The FDA Approval of Regeneron/Sanofi Praluent Is A Big Deal. Will the FDA Approve Nabriva Therapeutics’ Antibiotic Contepo Today?
Read More
April 30, 2019
0
Vertex Has Good News and Exelixis Is Reinforcing Its Outperformance
Read More
May 2, 2019
0
A Firm That Defied the Fierce Unwarranted Bear Market Day
Read More
May 7, 2019
0
Sanofi and Regeneron: Remarkable Results from Libtayo's Trial on Patients with Advanced Non-Small Cell Lung Cancer
Read More
April 27, 2020
0
Exelixis' and Daiichi Sankyo's Novel Antihypertensive Drug Minnebro® Hits the Japanese Market
Read More
May 13, 2019
0
Compugen Has Encouraging News
Read More
September 8, 2020
0
Regeneron: Why the FDA Approval of EYLEA for Diabetic Retinopathy is Extremely Important.
Read More
May 14, 2019
0
Another Late-Stage Firm with Impressive Technology and Promising Products
Read More
May 16, 2019
0
The Medicines Company: Are Inclisiran's Clinical Trial Results Impressive?
Read More
May 21, 2019
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)